Executive Leadership

Download Image

Michael Zinner, M.D.

CEO and Executive Medical Director of Miami Cancer Institute

Michael Zinner, M.D., is a world-renowned cancer surgeon and researcher. He was named founding CEO and executive medical director of Miami Cancer Institute at Baptist Health South Florida in October of 2015. An expert in pancreatic-hepatobiliary diseases, Dr. Zinner joined Miami Cancer Institute from Dana-Farber/Brigham and Women’s Cancer Center in Boston, where he was Clinical Director and Surgeon-in-Chief at the Brigham and Women’s Hospital from 1994 to 2015. He is also the Moseley Professor of Surgery, Emeritus at Harvard Medical School and founder of Harvard’s Center for Surgery and Public Health. Prior to his Boston experience, he was Chairman of the Department of Surgery at UCLA from 1988 to 1994.

Dr. Zinner was co-founder and co-director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, a multidisciplinary clinical program of surgeons, oncologists, radiation therapists, radiologists and pathologists. The author of more than 265 peer reviewed academic papers, he was a member of the editorial boards of Annals of Surgery, Journal of Gastrointestinal Surgery and the Journal of the American College of Surgeons. From 2008 to 2010, Dr. Zinner served as Chairman of the Board of Governors and then the Chairman of the Board of Regents from 2016 t0 2017 of the American College of Surgeons (ACS), which has more than 80,000 members. He was the former Chairman of the Health Policy and Advocacy Committee of the College.

Throughout his distinguished career, Dr. Zinner has been widely recognized for his extraordinary clinical accomplishments, his contributions to cancer treatment and research and his mentorship to students, physicians and researchers worldwide. A Miami native, Dr. Zinner received his M.D. degree from the University of Florida and did his surgical residencies at The Johns Hopkins Medical Institutes in Baltimore.